Cellontech Co., Ltd.
Clinical trials sponsored by Cellontech Co., Ltd., explained in plain language.
-
New bone graft shows promise for healing leg breaks
Disease control TerminatedThis study tested a new bone grafting material called SurgiFill™ in 60 people with broken thigh or shin bones. The goal was to see if it helps bones heal faster and safely. The study was stopped early, so results are limited.
Phase: NA • Sponsor: Cellontech Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Ankle cartilage repair trial halted early
Disease control TerminatedThis study tested a treatment called Chondron, which uses a person's own cartilage cells to repair damaged ankle cartilage. It included 28 people aged 15 to 65 with cartilage defects. The goal was to see if the treatment improved cartilage health and ankle function over 18 months…
Phase: PHASE3 • Sponsor: Cellontech Co., Ltd. • Aim: Disease control
Last updated Jun 01, 2026 17:58 UTC